Weichun Guo

238 Jiefang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

RNF130 inhibits the proliferation, migration and invasion of osteosarcoma through DAB1 mediated suppression of the PI3K/AKT signaling pathway.

RNF130 inhibits the proliferation, migration and invasion of osteosarcoma through DAB1 mediated suppression of the PI3K/AKT signaling pathway.

Journal: Cellular signalling

Published: January 12, 2026

IRF2BPL inhibits proliferation, migration and invasion of osteosarcoma cells by inhibiting FOSL2-mediated PI3K/AKT pathway activation.

IRF2BPL inhibits proliferation, migration and invasion of osteosarcoma cells by inhibiting FOSL2-mediated PI3K/AKT pathway activation.

Journal: Cellular signalling

Published: May 07, 2025

RNF207 promotes the proliferation, migration and invasion of osteosarcoma through KCNQ1 mediated activation of ERK/MEK signaling pathway.

RNF207 promotes the proliferation, migration and invasion of osteosarcoma through KCNQ1 mediated activation of ERK/MEK signaling pathway.

Journal: International immunopharmacology

Published: April 21, 2025

TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT/mTOR pathway activation through ubiquitination of FTO.

TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT/mTOR pathway activation through ubiquitination of FTO.

Journal: Cell death & disease

Published: March 31, 2025

HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway.

HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway.

Journal: Journal of translational medicine

Published: November 14, 2024

SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma.

SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma.

Journal: Journal of translational medicine

Published: August 23, 2024

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway.

CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway.

Journal: Molecular medicine (Cambridge, Mass.)

Published: August 18, 2024

The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion.

The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion.

Journal: Scientific reports

Published: April 10, 2024

ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.

ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.

Journal: Biology direct

Published: February 18, 2024

Surface functionalization of calcium magnesium phosphate cements with alginate sodium for enhanced bone regeneration via TRPM7/PI3K/Akt signaling pathway.

Surface functionalization of calcium magnesium phosphate cements with alginate sodium for enhanced bone regeneration via TRPM7/PI3K/Akt signaling pathway.

Journal: International journal of biological macromolecules

Published: January 06, 2024

SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway.

SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway.

Journal: Translational oncology

Published: July 07, 2023

Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.

Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.

Journal: BMC cancer

Published: June 28, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026